Clinical trial registry record

The Effect of Teleconsultation, on the Reversibility of Frailty in Geriatric Patients Post Hospitalization

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 22, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07712276
Last registry update
July 22, 2026
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Universitas Indonesia
Enrollment
116
Countries
Indonesia
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
116
Population
ALL · 60 Years
Duration
2026-08-03 to 2027-08-31
Intervention
structured teleconsultation and face to face consultation; face to face consultation
Comparator
face to face consultation group
Outcomes measured
Change in Clinical Frailty Scale (CFS) Score — Baseline (at hospital discharge) and Week 13 post-discharge; Change in Health Behavior — Baseline and Week 13 post-discharge; Change in Serum Albumin Level — Baseline and Week 13 post-discharge; Change in Serum Myostatin Level — Baseline and Week 13 post-discharge; Change in Hand Grip Strength — Baseline and Week 13 post-discharge; Change in IL-6 — Baseline and Week 13 post-discharge
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

frailty
Open primary sourceExport JSON